GSE176026
Transcriptional response to reverse-turn peptidomimetics in human colorectal cancer cells
HT29 cells were exposed to EC50 doses of reverse-turn peptidomimetic molecules ICG-001, CWP232228, and YB-0158 (vs. vehicle control DMSO) over 48 hours. RNA sequencing profiling was performed for each experimental condition. Overall design: Whole transcriptome profiling